REQUEST A DEMO
Total
USD $0.00
Search more companies

Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ardi Farma Ilac Pazarlama Ticaret Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ardi Farma Ilac Pazarlama Ticaret Limited Sirketi is a pharmaceutical company specializing in R&D. It offers specialized solutions to the pharmaceutical industry and develops new products for local and multinational companies. The company aims to be a key know-how exporting company with an enriched product portfolio.

Headquarters
Teknopark Bulvari 1/4a 101 Sanayi Mahallesi Pendik
Istanbul; Marmara; Postal Code: 34906

Contact Details: Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.

Website: http://www.ardifarma.com

Basic Information
Total Employees:
Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report to view the information.
Incorporation Date:
July 31, 2012
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Ardi Farma Ilac Pazarlama Ticaret Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
35.51%
Total operating revenue
35.51%
Operating profit (EBIT)
-78.31%
Net Profit (Loss) for the Period
N/A
Total assets
142.18%
Total equity
-91.21%
Operating Profit Margin (ROS)
-17.86%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
338.86%
Quick Ratio
0.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?